Pages that link to "Q27027238"

The following pages link to Unraveling the Interaction between FcRn and Albumin: Opportunities for Design of Albumin-Based Therapeutics (Q27027238):

Displaying 41 items.

• Analytical ultracentrifugation with fluorescence detection system reveals differences in complex formation between recombinant human TNF and different biological TNF antagonists in various environments (Q33641909) (← links)
• Mechanism of increased clearance of glycated albumin by proximal tubule cells (Q36957107) (← links)
• Fab-dsFv: A bispecific antibody format with extended serum half-life through albumin binding (Q37327316) (← links)
• Direct interaction of human serum proteins with AAV virions to enhance AAV transduction: immediate impact on clinical applications (Q37609090) (← links)
• Pharmacokinetic and pharmacodynamic considerations for the next generation protein therapeutics (Q38587550) (← links)
• Role of albumin and its modifications in glomerular injury (Q38653194) (← links)
• Serum Albumin Binding and Esterase Activity: Mechanistic Interactions with Organophosphates. (Q38674145) (← links)
• Half-life extended biotherapeutics (Q38770067) (← links)
• Toward in vitro-to-in vivo translation of monoclonal antibody pharmacokinetics: Application of a neonatal Fc receptor-mediated transcytosis assay to understand the interplaying clearance mechanisms. (Q38821056) (← links)
• Factors Affecting the FcRn-Mediated Transplacental Transfer of Antibodies and Implications for Vaccination in Pregnancy (Q45717061) (← links)
• Albumin/vaccine nanocomplexes that assemble in vivo for combination cancer immunotherapy. (Q46205951) (← links)
• Antibody blood-brain barrier efflux is modulated by glycan modification (Q46348633) (← links)
• Maillard Proteomics: Opening New Pages (Q47303198) (← links)
• Soluble interleukin-13rα1: a circulating regulator of glucose (Q47688975) (← links)
• Joint associations of blood plasma proteins with overwinter survival of a large mammal (Q47882777) (← links)
• A human endothelial cell-based recycling assay for screening of FcRn targeted molecules (Q49179176) (← links)
• Albumin-based drug delivery using cysteine 34 chemical conjugates - important considerations and requirements (Q50616154) (← links)
• Neonatal Fc receptor is involved in the protection of fibrinogen after its intake in peripheral blood mononuclear cells. (Q51740195) (← links)
• Directed evolution of broadly crossreactive chemokine-blocking antibodies efficacious in arthritis. (Q52589113) (← links)
• Hematopoietic cells as site of first-pass catabolism after subcutaneous dosing and contributors to systemic clearance of a monoclonal antibody in mice. (Q52604519) (← links)
• Half-life-extended recombinant coagulation factor IX-albumin fusion protein is recycled via the FcRn-mediated pathway. (Q52663655) (← links)
• Chemo- and Regioselective Lysine Modification on Native Proteins. (Q53081947) (← links)
• Patent highlights August-September 2016. (Q54076993) (← links)
• Neuropathogenesis of Zika Virus Infection : Potential Roles of Antibody-Mediated Pathology (Q56434705) (← links)
• Urinary Alpha-1-Acid Glycoprotein Is a Sensitive Marker of Glomerular Protein Leakage at Altitude (Q58723769) (← links)
• Diagnosis, Phenotype, and Molecular Genetics of Congenital Analbuminemia (Q64104972) (← links)
• The Discovery and Development of Liraglutide and Semaglutide (Q64118590) (← links)
• Multiple Glycation Sites in Blood Plasma Proteins as an Integrated Biomarker of Type 2 Diabetes Mellitus. (Q64914993) (← links)
• A Near-infrared Turn-on Fluorescent Sensor for Sensitive and Specific Detection of Albumin from Urine Samples (Q89896255) (← links)
• Harnessing albumin as a carrier for cancer therapies (Q90251494) (← links)
• Mechanisms of palmitic acid-conjugated antisense oligonucleotide distribution in mice (Q90391306) (← links)
• Possible Mechanisms by Which Enzymatic Degradation of Human Serum Albumin Can Lead to Bioactive Peptides and Biomarkers (Q90432003) (← links)
• Neonatal Fc receptor antagonist efgartigimod safely and sustainably reduces IgGs in humans (Q90438756) (← links)
• Human serum albumin presents isoform variants with altered neonatal Fc receptor interactions (Q90474806) (← links)
• Antibody-mediated oral delivery of therapeutic DNA for type 2 diabetes mellitus (Q90676600) (← links)
• Phase 2 study of efgartigimod, a novel FcRn antagonist, in adult patients with primary immune thrombocytopenia (Q91845137) (← links)
• An overview of albumin and alpha-1-acid glycoprotein main characteristics: highlighting the roles of amino acids in binding kinetics and molecular interactions (Q92029725) (← links)
• Vascularized Microfluidics and the Blood-Endothelium Interface (Q92257481) (← links)
• Murine models for studying treatment, prevention and pathogenesis of FNAIT (Q92710107) (← links)
• Albumin Nanovectors in Cancer Therapy and Imaging (Q92724157) (← links)
• Long-Circulating Amphiphilic Doxorubicin for Tumor Mitochondria-Specific Targeting (Q93385365) (← links)